Abstract
A case in which a self-expandable biodegradable (BD) esophageal stent was used for a refractory esophageal anastomotic stricture (EAS) in a 5-year-old female is presented. The patient underwent closure of a tracheoesophageal fistula and gastrostomy in the neonatal period. Esophagoesophagostomy was performed at 18 months of age after a multistaged extrathoracic esophageal elongation procedure. The patient developed refractory EAS and required repeated esophageal balloon dilation. Four sessions of esophageal BD stenting were performed from the age of 5–8 years. Each BD stenting allowed her to eat chopped food, but the anastomotic stricture recurred 4–7 months after the procedure. No major complications were observed, though transient chest pain and dysphagia were observed after each stenting. Finally, at 8 years of age, EAS resection and esophagoesophageal anastomosis were performed. The resected specimens showed thickened scar formation at the EAS lesion, while the degree of esophageal wall damage, both at the proximal and distal ends of the stricture, was slight. To the best of our knowledge, this is the first case report of this kind of treatment and assessment of damage to the esophageal wall microscopically. The advantages and problems of the use of BD stents in children are discussed.
Similar content being viewed by others
References
Serhal L, Gottrand F, Sfeir R, et al. Anastomotic stricture after surgical repair of esophageal atresia: frequency, risk factors, and efficacy of esophageal bougie dilatations. J Pediatr Surg. 2010;45:1459–62. doi:10.1016/j.jpedsurg.2009.11.002.
Repici A, Vleggaar FP, Hassan C, et al. Efficacy and safety of biodegradable stents for refractory benign esophageal strictures: the BEST (Biodegradable Esophageal Stent) study. Gastrointest Endosc. 2010;72:927–34. doi:10.1016/j.gie.2010.07.031.
van Hooft JE, van Berge Henegouwen MI, Rauws EA, et al. Endoscopic treatment of benign anastomotic esophagogastric strictures with a biodegradable stent. Gastrointest Endosc. 2011;73:1043–7. doi:10.1016/j.gie.2011.01.001.
Kimura K, Nishijima E, Tsugawa C, et al. Multistaged extrathoracic esophageal elongation procedure for long gap esophageal atresia: experience with 12 patients. J Pediatr Surg. 2001;36:1725–7. doi:10.1053/jpsu.2001.27976.
Takamizawa S, Nishijima E, Tsugawa C, et al. Multistaged esophageal elongation technique for long gap esophageal atresia: experience with 7 cases at a single institution. J Pediatr Surg. 2005;40:781–4. doi:10.1016/j.jpedsurg.2005.01.041.
Takamizawa S, Yamanouchi E, Muraji T, et al. MCRA of an anastomotic stenosis after esophagoesophagostomy for long gap esophageal atresia: a case report. J Pediatr Surg. 2007;42:769–72. doi:10.1016/j.jpedsurg.2006.12.042.
Siersema PD. Stenting for benign esophageal strictures. Endoscopy. 2009;41:363–73. doi:10.1055/s-0029-1214532.
Sharma P, Kozarek R. Role of esophageal stents in benign and malignant diseases. Am J Gastroenterol. 2010;105:258–73. doi:10.1038/ajg.2009.684 quiz 274.
Ham YH, Kim GH. Plastic and biodegradable stents for complex and refractory benign esophageal strictures. Clin Endosc. 2014;47:295–300. doi:10.5946/ce.2014.47.4.295.
Kramer RE, Quiros JA. Esophageal stents for severe strictures in young children: experience, benefits, and risk. Curr Gastroenterol Rep. 2010;12:203–10. doi:10.1007/s11894-010-0105-4.
Best C, Sudel B, Foker JE, et al. Esophageal stenting in children: indications, application, effectiveness, and complications. Gastrointest Endosc. 2009;70:1248–53. doi:10.1016/j.gie.2009.07.022.
van Boeckel PG, Vleggaar FP, Siersema PD. A comparison of temporary self-expanding plastic and biodegradable stents for refractory benign esophageal strictures. Clin Gastroenterol Hepatol. 2011;9:653–9. doi:10.1016/j.cgh.2011.04.006.
Vandenplas Y, Hauser B, Devreker T, et al. A biodegradable esophageal stent in the treatment of a corrosive esophageal stenosis in a child. J Pediatr Gastroenterol Nutr. 2009;49:254–7. doi:10.1097/MPG.0b013e31819de871.
Basha J, Appasani S, Vaiphei K, et al. Biodegradable stents: truly biodegradable with good tissue harmony. Endoscopy. 2013;45 Suppl 2 UCTN:E116-117 doi:10.1055/s-0032-1326111.
Okata Y, Hisamatsu C, Nishijima E, et al. Topical application of basic fibroblast growth factor reduces esophageal stricture and esophageal neural damage after sodium hydroxide-induced esophagitis in rats. Pediatr Surg Int. 2012;28:43–9. doi:10.1007/s00383-011-3007-0.
Disclosures
Conflict of Interest:
Yuichi Okata, Chieko Hisamatsu, Yuko Bitoh, Akiko Yokoi, Eiji Nishijima, Makiko Yoshida, Tsukasa Ishida, Takeshi Azuma, Kosaku Maeda, and Hiromu Kutusmi declare that they have no conflict of interest.
Human/Animal Rights:
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008(5).
Informed Consent:
Informed consent was obtained from all patients for being included in the study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Okata, Y., Hisamatsu, C., Bitoh, Y. et al. Efficacy and histopathological esophageal wall damage of biodegradable esophageal stents for treatment of severe refractory esophageal anastomotic stricture in a child with long gap esophageal atresia. Clin J Gastroenterol 7, 496–501 (2014). https://doi.org/10.1007/s12328-014-0537-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12328-014-0537-8